MTRY NASDAQ
Monterey Bio Acquisition Corporation
1W: +0.0%
1M: -1.4%
3M: -0.1%
1Y: +9.0%
$11.14
Last traded 2023-11-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$2M
+0.0% ▲
Operating Income
-$2M
-289.9% ▼
Net Income
-$1M
-119.3% ▼
EPS (Diluted)
$-0.44
-989.1% ▼
EBITDA
-$2M
-289.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $523K | $2M |
| Gross Profit | $0 | $0 | -$2M |
| Gross Margin | — | — | — |
| R&D Expenses | $0 | $0 | $0 |
| SG&A Expenses | $2 | $523K | $2K |
| Operating Expenses | $2 | $523K | $2M |
| Operating Income | -$2 | -$523K | -$2M |
| Operating Margin | — | — | — |
| Interest Expense | $0 | $0 | $0 |
| Income Before Tax | -$2 | -$583K | -$1M |
| Tax Expense | $0 | -$2K | $116K |
| Net Income | -$2 | -$581K | -$1M |
| Net Margin | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.04 | $-0.44 |
| EBITDA | $0 | -$523K | -$2M |
| Shares Outstanding | 2M | 14M | 3M |